Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103069324 | 10306932 | 4 | F | 20120502 | 20150623 | 20140715 | 20150630 | EXP | JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2012-BP-20999NB | BOEHRINGER INGELHEIM | 70.59 | YR | F | Y | 45.00000 | KG | 20150630 | N | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103069324 | 10306932 | 1 | PS | PRAZAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 220 MG | D | 22512 | 110 | MG | CAPSULE | BID | |||||
| 103069324 | 10306932 | 2 | C | HALFDIGOXIN | DIGOXIN | 1 | Oral | 0.125 MG | D | 0 | .125 | MG | QD | ||||||
| 103069324 | 10306932 | 3 | C | ARTIST | CARVEDILOL | 1 | Oral | 10 MG | D | 0 | 10 | MG | QD | ||||||
| 103069324 | 10306932 | 4 | C | DEPAS | ETIZOLAM | 1 | Oral | 1 MG | D | 0 | .5 | MG | BID | ||||||
| 103069324 | 10306932 | 5 | C | TAKEPRON | LANSOPRAZOLE | 1 | Oral | 15 MG | D | 0 | 15 | MG | QD | ||||||
| 103069324 | 10306932 | 6 | C | LENDORMIN D | BROTIZOLAM | 1 | Oral | 0.25 MG | D | 0 | .25 | MG | QD | ||||||
| 103069324 | 10306932 | 7 | C | EQUA | VILDAGLIPTIN | 1 | Oral | 1 MG | D | 0 | 1 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103069324 | 10306932 | 1 | Thrombosis prophylaxis |
| 103069324 | 10306932 | 2 | Atrial fibrillation |
| 103069324 | 10306932 | 3 | Product used for unknown indication |
| 103069324 | 10306932 | 4 | Product used for unknown indication |
| 103069324 | 10306932 | 5 | Prophylaxis |
| 103069324 | 10306932 | 6 | Product used for unknown indication |
| 103069324 | 10306932 | 7 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103069324 | 10306932 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103069324 | 10306932 | Blood urine present | |
| 103069324 | 10306932 | Cataract | |
| 103069324 | 10306932 | Diabetes mellitus | |
| 103069324 | 10306932 | Dyspepsia | |
| 103069324 | 10306932 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103069324 | 10306932 | 1 | 20120404 | 0 |